Published in Clin Genet on October 25, 2013
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
Surveillance of endophthalmitis following cataract surgery in the UK. Eye (Lond) (2004) 3.07
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet (2005) 2.92
Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye (Lond) (2006) 2.56
MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol (1992) 2.48
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology (1994) 2.00
Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods (2003) 1.99
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol (1999) 1.95
Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia (1997) 1.82
Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology (2001) 1.68
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology (2009) 1.65
GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology (2000) 1.64
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol (2012) 1.62
Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology (1997) 1.58
Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis. Neuropediatrics (2007) 1.53
Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol (2012) 1.49
Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest (1995) 1.45
Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. J Neurol Sci (2007) 1.44
Ekbom's syndrome: lipomas, ataxia, and neuropathy with MERRF. Muscle Nerve (1994) 1.44
Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family. Neurology (2001) 1.43
Lipoid proteinosis: case report and review of the literature. Acta Otorhinolaryngol Ital (2006) 1.42
Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol (2007) 1.39
Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord (1993) 1.38
Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys. Eur J Immunol (2000) 1.35
Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes (1991) 1.30
Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat (2008) 1.27
Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. Neurology (2004) 1.26
Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest (2001) 1.22
Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology (2005) 1.19
Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys. J Virol (2006) 1.17
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease. Parkinsonism Relat Disord (2008) 1.16
Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology (1991) 1.16
A novel mutation in SACS gene in a family from southern Italy. Neurology (2004) 1.15
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology (2006) 1.15
Retinal changes associated with type 2 glomerulonephritis. Eye (Lond) (2005) 1.15
Mutational screening of VSX1 in keratoconus patients from the European population. Eye (Lond) (2009) 1.14
A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy. Hum Mutat (1994) 1.13
Anaesthetic management of a child with fibrodysplasia ossificans progressiva. Br J Anaesth (2006) 1.13
Apoptosis in SIV infection. Cell Death Differ (2005) 1.12
Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology (1991) 1.10
A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia. Clin Neurol Neurosurg (2010) 1.08
Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies. Neurology (2010) 1.07
SPG3A: An additional family carrying a new atlastin mutation. Neurology (2002) 1.07
Measuring T cell-mediated cytotoxicity using fluorogenic caspase substrates. Methods (2003) 1.07
Clinical and molecular findings in patients with giant axonal neuropathy (GAN). Neurology (2004) 1.06
Maternally inherited Leigh syndrome. J Pediatr (1993) 1.05
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene. Neurology (2002) 1.04
Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts. Neurology (2003) 1.04
Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology (1998) 1.02
Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr (1992) 1.01
About the "Pathological" role of the mtDNA T3308C mutationellipsis. Am J Hum Genet (1999) 1.00
CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol (2007) 1.00
Clinical features associated with the A-->G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology (1993) 0.99
A novel ATP1A2 mutation in a family with FHM type II. Cephalalgia (2006) 0.99
Cell-cycle dysregulation in the immunopathogenesis of AIDS. Immunol Res (2004) 0.99
Maternally inherited cardiomyopathy: an atypical presentation of the mtDNA 12S rRNA gene A1555G mutation. Am J Hum Genet (1999) 0.98
Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain (2000) 0.98
Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals. J Virol (2001) 0.98
Novel L2HGDH mutations in 21 patients with L-2-hydroxyglutaric aciduria of Portuguese origin. Hum Mutat (2005) 0.97
Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene. Neurology (2004) 0.97
A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun (1995) 0.96
Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology (2004) 0.95
POMT2 mutation in a patient with 'MEB-like' phenotype. Neuromuscul Disord (2006) 0.95
Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord (2003) 0.95
Changes of autonomic cardiac profile after a 3-week integrated body weight reduction program in severely obese patients. J Endocrinol Invest (2003) 0.95
Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis (1996) 0.95
Chronic autoimmune autonomic neuropathy responsive to immunosuppressive therapy. Neurology (2007) 0.94
Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients. AIDS (1999) 0.94
Maternally inherited deafness associated with a T1095C mutation in the mDNA. Eur J Hum Genet (2001) 0.94
A new mtDNA mutation associated with a progressive encephalopathy and cytochrome c oxidase deficiency. Neurology (2000) 0.94
Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum Mutat (2001) 0.94
Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology (2003) 0.94
Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology (1996) 0.94
Localisation of a gene for central areolar choroidal dystrophy to chromosome 17p. Hum Mol Genet (1996) 0.93
Muscle MRI in TRPV4-related congenital distal SMA. Neurology (2012) 0.93
Homozygosity mapping of Marinesco-Sjögren syndrome to 5q31. Eur J Hum Genet (2003) 0.92
Cytochrome c oxidase-deficient patients have distinct subunit assembly profiles. J Biol Chem (2001) 0.92
A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathy. J Neurol (2006) 0.92
Intrafamilial variability in hereditary spastic paraplegia associated with an SPG4 gene mutation. Neurology (2000) 0.92
Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: a clinical and muscle MRI study. Neuromuscul Disord (2013) 0.92
A 14-yr-old male with dyspnoea, productive cough and chest pain. Eur Respir J (2003) 0.91
Myelinated retinal fibers in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Eur J Neurol (2011) 0.91
HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentation. J Inherit Metab Dis (2006) 0.91
The T9176G mtDNA mutation severely affects ATP production and results in Leigh syndrome. Neurology (2001) 0.91
Further pitfalls in the diagnosis of mtDNA mutations: homoplasmic mt-tRNA mutations. J Med Genet (2008) 0.90
Detection of beta-A4 amyloid and its precursor protein in the muscle of a patient with juvenile neuronal ceroid lipofuscinosis (Spielmeyer-Vogt-Sjögren). Acta Neuropathol (1999) 0.90